Having trouble accessing articles? Reset your cache.

DEGS1 inhibition for insulin resistance and hepatic steatosis

DISEASE CATEGORY: Endocrine/metabolic; hepatic

INDICATION: Diabetes; hepatic

A University of Utah team led by Centaurus Therapeutics

Read the full 155 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE